EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57

Abstract

PREVALENCE AND CHARACTERISTICS OF COMORBID CONDITIONS IN PATIENTS WITH CARDIOVASCULAR DISEASES

Urinov O. U.*, Fozilov Kh. G., Abidova D. E., and Boboev R. R.

ABSTRACT

Objective:
To determine the prevalence, structure, and clinical characteristics of comorbid conditions in patients
with cardiovascular diseases (CVD) in order to optimize diagnostic and treatment strategies. Mater ials and
Methods: A prospective cohort study was conducted among 1,220 patients (705 men [57.8%], 515 women
[42.2%]) at the Republican Specialized Scientific Practical Medical Center of Cardiology (Tashkent). • Mean age:
62.01 ± 9.83 years (men: 60.50 ± 10 .04, women: 64.08 ± 9.14). • Age range: 18 to 90 years. • Inclusion criteria:
confirmed CVD (stable angina, hypertension, CHF) and comorbidities (T2DM, CKD, COPD, previous COVID
19), with informed consent. • Control group: 214 patients (17.5%) with isolate d CVD. • Study group: 1,006
patients (82.5%) with comorbidities. • Diagnoses were established according to clinical guidelines. Results •
Comorbidity was found in 82.5% of patients with CVD. • The most frequent combinations were: o CVD + COPD
( esp ecially in age groups 45 59 (18.6%, p = 0.029) and 60 74 (18.7%, p = 0.026) o CVD + T2DM
(15.2% in ages 45 59), declining to 10.2% in those over 75 o CVD + CKD peaked in ages 60 74 (13.8%, p =
0.048). Conclusion : Comorbid conditions in CVD patients demons trate clear age and sex differences. The
combinations of CVD with COPD and T2DM are most prevalent among middle aged and elderly individuals,
while CKD is more common in those aged 60 74. Men are more susceptible to CVD + COPD + CKD, whereas
women more oft en suffer from CVD + T2DM + CKD.

Keywords: Cardiovascular diseases, Comorbidity, Chronic obstructive pulmonary disease, Type 2 diabetes mellitus, Chronic kidney disease, Arterial hypertension.


[Full Text Article] [Download Certificate]

Citation

  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 May 2025 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR: MAY ISSUE PUBLISHED

    MAY 2025 issue has been successfully launched on MAY 2025.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along witcertificate to promote resear activity of scholar.

Best Article of current issue :

Dr. Kartik Neog
Download Article : Click here